Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...

While we've tested all kinds of the best vacuums, including premium splurge models that retail for nearly $2,000, we've found that a modest threshold of $200 can get you a solid and reliable vacuum.

Learn everything you need to know about iShares Russell Top 200 Growth ETF (IWY) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's ...